Search within:  

Sort results by:      



1-17 of 17  
 
1.  
Recommendations for drug therapies for relapsing-remitting multiple sclerosis. 2013 Oct. NGC:010418
Canadian Agency for Drugs and Technologies in Health - Nonprofit Organization. View all guidelines by the developer(s)
2.  
Infectious diseases. 2013 Jun 28. NGC:010128
Work Loss Data Institute - For Profit Organization. View all guidelines by the developer(s)
3.  
Fingolimod for the treatment of highly active relapsing-remitting multiple sclerosis. 2012 Apr. NGC:009075
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
6.  
Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. 2011 Jun. NGC:009009
American Association of Clinical Endocrinologists - Medical Specialty Society; American Thyroid Association - Professional Association. View all guidelines by the developer(s)
7.  
Multifocal motor neuropathy. 2006 Mar (revised 2011). NGC:008775
European Academy of Neurology - Medical Specialty Society. View all guidelines by the developer(s)
8.  
9.  
Interstitial lung disease. In: Pulmonary (acute & chronic). 2009 Jan (revised 2013 Oct 29). NGC:010119
Work Loss Data Institute - For Profit Organization. View all guidelines by the developer(s)
10.  
11.  
Guidelines for the diagnosis and management of multiple myeloma 2013. 2006 Feb (revised 2013). NGC:010002
British Committee for Standards in Haematology - Professional Association. View all guidelines by the developer(s)
12.  
Lymphoma. 2012 Sep (revised 2013 Apr). NGC:010256
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
13.  
Guidelines for the management of hemophilia. 2012. NGC:009524
World Federation of Hemophilia - Nonprofit Organization. View all guidelines by the developer(s)
14.  
Alemtuzumab for treating relapsing–remitting multiple sclerosis. 2014 May. NGC:010430
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
15.  
Dimethyl fumarate for treating relapsing-remitting multiple sclerosis. 2014 Aug. NGC:010519
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
16.  
Teriflunomide for treating relapsing–remitting multiple sclerosis. 2014 Jan. NGC:010284
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
17.  
Nursing management of the patient with multiple sclerosis. 2011. NGC:009286
American Association of Neuroscience Nurses - Professional Association; Association of Rehabilitation Nurses - Professional Association; International Organization of Multiple Sclerosis Nurses - Professional Association. View all guidelines by the developer(s)
1-17 of 17